2015 ASM Program

Program Overview

Click here to view the program in PDF.

The supplement for Nephrology/volume 20/supplement 3 is now published online. You may now access the supplement through Wiley Online Library (WOL) or via this link:http://onlinelibrary.wiley.com/doi/10.1111/nep.2015.20.issue-s3/issuetoc

Saturday 5 September 2015
Nephrology and Transplantation Update Course | Bradman Theatrette
Chair: Wai Lim
0800 Course Registration
0830-0900 Renovascular hypertension
George Mangos
0900-0930 Glucocorticoid-induced hypertension
Sharon Ong
0930-1000 Poisoning
Darren Roberts
1000-1030 Morning Tea
1030-1100 Assessment of the recipient
Wai Lim
1100-1130 Tissue typing
Jeremy Chapman
1130-1215 Assessment of the living donor
John Gill
1215-1315 Lunch
Chair: Vincent Lee
1315-1345 Pathology – SLE
Prue Hill
1345-1415 Pathology – Transplantation
Alison Skene
1415-1445 Afternoon Tea
1445-1530 The role of the proximal tubule in regulating albuminuria
Prof Bruce Molitoris
1530-1600 HUS
Nikky Isbel
1600-1630 BP trials
Len Arnolda
1630 Course concludes
1815 Coaches depart Crowne Plaza for The National Portrait Gallery

Update Course Dinner | The National Portrait Gallery


Sunday 6 September 2015
0900-1600 ANZSN Council Meeting | Torrens Room, National Convention Centre
1100-1900 ANZSN and Aust NZ Bone and Mineral Society (ANZBMS) Meeting | Swan Boardroom, National Convention Centre
Nephrology & Transplantation Update Course (continued) | Bradman Theatrette Renal Dietitians Day Workshop | Menzies Theatrette
Chair: Kevan Polkinghorne
0800 Course Registration 0900 Course Registration
0830-0900 Creating and maintaining vascular access
Richard Allen
0930-1000 IG meeting and update
0900-0930 Haemodialysis access monitoring
Lukas Kairaitis
1000-1100 Dietetic involvement in clinical trials or research – The how and why to get involved
Katrina Campbell, Kelly Lambert
0930-1000 New technology in HD
Peter Kerr
1100-1130 Quality projects
1000-1030 Morning Tea 1130-1200 Morning Tea
1030-1100 Complications in HD: volume control
Kevan Polkinghorne
1200-1230 Diet and the gut microbiota: An essential guide for renal dietitians
Katrina Campbell
1100-1130 Water Management
Maureen Lonergan
1230-1300 Health literacy: What every renal dietitian needs to know
Kelly Lambert
1130-1215 Dialysis vascular access: Challenges and opportunities
Prabir Roy-Chaudhury
1300-1305 Advances in non-calcium phosphate binders 
Peter Grudzinskas, Fresenius
1215-1315 Lunch 1305-1345 Lunch ANZSN Renal Scientists Workshop | Nicholls Theatrette
1245-1315 Advanced Trainee Forum | Bradman Theatrette
1315-1345 Chair: Sean Kennedy 1345-1415 The experience of chronic kidney disease and eating behaviour change for pre-dialysis patients
Stephanie Notaras
1330 Welcome
CKD in adolescents and early adulthood
Sean Kennedy
Session 1
1340-1410 Adenine model of chronic kidney disease
Glenda Gobe
1345-1415 CKD in pregnancy
Vincent Lee
1415-1515 Exercise in CKD
Anthony Meade
1410-1440 Streptozoctin-induced Diabetic Nephropathy in eNOS KO mice
Usha Panchapakesan
1415-1445 CKD in the elderly: Dialysis / transplantation
Celine Foote
1515-1630 Two fruit/three veg. Does it still apply in CKD
Maria Chan, Anthony Meade, Karen Salamon
1440-1510 Techniques for analysing kidney fibrosis
Chrishan Samuel
1445-1515 Afternoon Tea 1630 Close 1510-1530 Afternoon Tea
1515-1600 PD infections
Sunil Badve
Session 2
1530-1600 Role of mitochondrial dysfunction in kidney disease
Melinda Coughlan
1600-1645 PD update
Kamal Sud
1600-1630 Strategies for therapeutic targeting of kinase enzymes in kidney disease
Frank Ma
1645 Course close 1630 Close
1900 President’s Dinner | The Boathouse


Monday 7 September 2015
0730 Registration Desk & Speakers Preparation Room Open | National Convention Centre Foyer
Plenary 1 | Royal Theatre
Chair: Peter Kerr
0820 Welcome to Delegates
Welcome to Country
0830-0930 Opening Keynote: Professor Prabir Roy-Chaudhury
Dialysis vascular access: A tale of biology, technology and process of care
Awards | Royal Theatre
Chair: Alan Cass
0930-0940 Invited Speaker: Judith Whitworth
Remembering Priscilla Kincaid Smith
0940-1005 TJ Neale Award: Stephen McDonald
1005-1030 Jacquot Award Past Recipients: Suetonia Palmer and Jonathan Gleadle
1030-1100 Morning Tea | Exhibition Area
Young Investigator Award | Royal Theatre
Chair: Toby Coates
1100-1115 Impact of ischemic time on live-donor kidney transplantation: Graft and patient outcomes
Anoushka Krishnan
1115-1130 HMGB1 A box attenuates diabetic kidney injury in mice
Xiaochen Chen
1130-1145 Relative benefits and costs of an acceptable HLA mismatch program in Australia
Hung Do Nguyen
1145-1200 Complement acting through the C5A receptor mediates anti-myeloperoxidase auto-immunity and glomerulonephritis
Jonathan Dick
1200-1215 Effects of a three year lifestyle intervention on cardiorespiratory fitness and exercise capacity in patients with chronic kidney disease 
Kassia Beetham
1215-1230 Human amniotic epithelial derived stem cells attenuate anti-myeloperoxidase glomerulonephritis
Andrea Godfrey
1230-1245 The hint study: A cross-sectional survey of nephrologists on hepatitis transmission risk in solid organ transplantation
Karen Waller
1245-1300 BANK1: A critical genetic determinant of B-cell systemic lupus erythematosus
Simon Jiang
1300-1400 Lunch | Exhibition Area
CREED AGM (members only) | Boardroom 1
Mini Orals | 5 minute presentation + 2 minutes for questions
Basic Science 1 | Royal Theatre
Chairs: Peter Mount & Guoping Zheng
Epidemiology 1 | Bradman Theatrette
Chairs: Meg Jardine & Wai Lim
AKI and Cardiovascular | Menzies Theatrette
Chairs: Zoltan Endre & Steve Holt
1400-1530 Cell based therapy in combination with serelaxin is critical for preservation of vascular integrity via promotion of angiogenesis and anastomosis
Brooke Huuskes
Booster hepatitis B vaccination in haemodialysis patients: A 5-year prospective study
Casey Light
Dichloroacetate (DCA) prevents cisplatin-induced acute kidney injury (AKI) by regenerating renal tubular cells while anticancer activity of cisplatin is unaltered
Ramindhu Galgamuwa Arachchige
KCA3.1 regulates tubular autophagy in diabetic kidneys via PI3K/AKT/MTOR signaling pathways
Chunling Huang
Estimating the annual incidence of end-stage kidney disease in Fiji
Amrish Krishnan
Long-term renal outcomes following VV-ECMO associated acute kidney injury
Tim Coughlan
Cyclophilin D promotes interstitial fibrosis in the obstructed kidney
Frank Ma
Are repeated measures of EGFR superior to a single measure in elderly women?
Vinothkumar Kavarthapol Jayamaran
Chronic kidney disease is associated with progressive increase in arterial stiffness and bone-muscle loss over 1 year
Rathika Krishnasamy
Deleterious effect of NADPH oxidase-NOX5 in diabetic nephropathy 
Jay Jha
Scope and consistency of outcomes reported in randomised trials of haemodialysis 
Gabrielle Williams
Effects of catheter-based renal denervation in hypertensive sheep with chronic kidney disease
Reetu Singh
In DB/DB mice, SGLT2 inhibition does not improve diabetic nephropathy despite glycaemic improvements
Linda A Gallo
The effect of expanded criteria deceased donation on the mortality risk of younger and older kidney transplant recipients
Germaine Wong
Effect of exercise and lifestyle intervention on oxidative stress in chronic kidney disease
Glenda Gobe
Targeting B-Catenin/FOXO to dissociate profibrotic from anti-inflammatory effects of TGF-B for optimised treatment of chronic kidney disease
Guoping Zheng
Total fluid intake and risk of mortality in older women
Wai Lim
High dose vitamin-D induced accelerated vascular calcification is associated with arterial macrophage infiltration and elevation of TLR4 expression
Jimmy Jianheng Zhou
The potential renoprotection of metformin in renal fibrosis
Hao Yi
Cognition in chronic kidney disease: A systematic review
Israel Berger
Reduced cortisol inactivation and hypertension in chronic kidney disease
John J Kelly
FGF23 is synthesised locally by renal proximal tubular cells and may be pro-fibrotic
Edward Smith
They don’t do well, do they? Survival of propensity matched Indigenous transplant and dialysis patients
Paul Lawton
Renal and cardiac pathology in Fabry disease after 13 years on enzyme replacement therapy
Andrew Talbot
Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells
Robert Ellis
Albuminuria is a critical determinant of CKD progession among Indigenous Australian adults: The eGFR follow-up study
Alan Cass
Treatment adherence in clinical trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review
Karumathil Murali
Podocyte adaptation in a mouse model of conditional podocyte depletion
Victor Puelles
The registration of randomised trials in nephrology: An international review
Tadashi Toyama
Changes in high sensitivity troponin T in incident haemodialysis patients
Tze Liang Goh
Impaired autophagy in the proximal tubules is associated with the progession of diabetic nephropathy
Gavin Higgins
Educational interventions for patients with early stage chronic kidney disease: A systematic review
Pamela Lopez-Vargas
Mortality in early days after acute initiation of hemodialysis patients
Vidhia Umami
Animal models of diabetes obesity
Sarah Glastras
The predictive value of lower GFR on risk for future incident albuminuria: Towards a renal disease model based on relative oligonephropathy in remote-living Aboriginal people
Wendy Hoy
Relationship between peritoneal dialysis catheter line changes and peritoneal dialysis associated peritonitis
Nicole Lioufas
1530-1600 Afternoon Tea | Exhibition Area
Seminar 1 Basic Science | Royal Theatre
The path to CKD: Cellular responses and targeted therapies
Chair: David Nikolic-Paterson
KHA Clinical Science Award | Bradman Theatrette
10 minute presentation + 5 minutes for questions
Chair: Angela Webster
1600-1615 The gold rush to treat AKI: New investments, progress and pathways under study
Professor Bruce Molitoris
Association between human leukocyte antigen (HLA)-DQ mismatches and rejection and graft loss in kidney transplant recipients
Wai Lim
1615-1630 Factors influencing progression of chronic kidney disease: A 14 year prospective study of the AUSDIAB cohort
Melanie Wyld
1630-1645 Humoral and cellular immunity as a therapeutic target in CKD
Professor David Harris
Human fetal kidney volume in gestational diabetes
Stacey Hokke
1645-1700 Decline in estimated glomerular filtration rate and subsequent risk of graft failure and mortality among kidney transplant recipients
Steven Chadban
1700-1715 Progression of fibrosis – Does reality always bite?
A/Professor Tim Hewitson
Estimated glomerular filtration rate based on cystatin C is strongly associated with an increased risk of all-cause and cardiovascular disease mortality in the general population: A 14 year follow-up of the AUSDIAB study
Kevan Polkinghorne
1715-1730 Detecting bowel cancer in chronic kidney disease (CKD): The detect study
Germaine Wong
1730-1815 ANZSN Annual General Meeting | Royal Theatre
1830-2000 Welcome Reception in the Exhibition Area


Tuesday 8 September 2015
0715-0815 Australasian Kidney Trials Network Breakfast Meeting Torrens Room (bookings essential)
From hypothesis to publication: How the AKTN can enable your research plan
0730 Registration Desk & Speakers Preparation Room Open | National Convention Centre Foyer
Plenary 2 | Royal Theatre
Chair: David Harris
0830-0930 Keynote Speaker: Professor Bruce Molitoris
Understanding AKI and the necessary requirements for therapeutic translation
Seminar 2 Basic Science | Royal Theatre
Advances in kidney disease modelling and treatments
Chair: Sharon Ricardo
ANZDATA Session | Bradman Theatrette
Chairs: Matthew Jose & Stephen McDonald
0930-1000 Mapping the renal ubiquitome in health and disease
Professor Phil Poronnik
ANZDATA Overview
Matthew JoseDialysis Modality and Survival in ANZDATA – Marginal Structural Models and the effect is Haemodialysis Vascular Access. 
Kevan PolkinghorneWhy don’t indigenous dialysis patients receive transplants – waitlist or allocation?
Namrata KhanalAccuracy and utility of ANZDATA registry in kidney transplantation
Wai LimMythbusters – popular misconceptions about RRT trends
Stephen McDonald
1000-1030 Genetic and cellular control of autoantibody responses 
Professor Carola Vinuesa
1030-1100 Cilia and PKD – Use of a novel mouse model
A/Professor Carol Wicking
1100-1130 Morning Tea | Exhibition Area
Annual ANZSN Renal Scientists Meeting | Green Room
Mini Orals | 5 minute presentation + 2 minutes for questions
Glomeruonephritis | Royal Theatre
Chair: Giles Walters & Stephen Holdsworth
Transplantation 1 | Bradman Theatrette
Chairs: Frank Ierino & Darren Lee
Basic Science 2 | Menzies Theatrette
Chairs: Greg Tesch & Muh Geot Wong
1130-1300 Use of CRISPR technique to correct a gene defect in X-linked Alport syndrome due to a missense mutation in the COL4A5 gene
Judy Savige
Validation of the kidney donor risk index (KDRI) in the Australian and New Zealand kidney transplant population
Steven Chadban
Transforming growth factor ß-activated kinase 1 (TAK1) attenuates experimental glomerulonephritis
Liv Amos
A role for MMP-9 in glomerulosclerosis
Guoping Zheng
Kidney donor risk index versus estimated post-transplant survival among Australian donor-recipient pairs
Steven Chadban
Blockade of apoptosis signal-regulating kinase 1 (ASK1) inhibits renal inflammation and fibrosis in a rat model of crescentic glomerulonephritis
Liv Amos
The reno-protective role of MicroRNA-378
Sharon Ricardo
Change in panel reactive antobody (PRA) and kidney transplant outcomes
Wai Lim
CD40 DNA vaccine targeting dendritic cells protects against experimental autoimmune glomerulonephritis by suppressing TH17 differentiation
Yiping Wang
Suppression of mouse crescentic glomerulonephritis with a non-steroidal mineralocorticoid receptor antagonist
Greg Tesch
The association between HLA eplet mismatches, broad antigen mismatches and clinical outcomes in kidney transplantation
Hung Do Nguyen
CD103+ dendric cells elicit CD8+ T cell responses to accelerate kidney injury in adriamycin nephropathy
Qi Cao
Analysis of clinical presentation, pathological spectra, treatment and outcomes of biopsy-proven acute post infectious glomerulonephritis (APIGN) in the Northern Territory
Sandawana William Majoni
Characterising potential intended and actual kidney donors in NSW: A cohort study 2011-2014
Angela Webster
Increased recruitment of human lymphocyte subsets in renal fibrosis and chronic kidney disease
Andrew Kassianos
P2X7 receptor blockade protects against kidney injury in chronic kidney disease model
Yuan Min Wang
Induction therapy and graft outcomes in paediatric kidney transplant recipients
Wai Lim
The T616C TRNA(PHE) mutation causes mitochondrially inherited tubulointerstitial kidney disease
Andrew Mallett
The spectrum of glomerulonephritis and end stage renal disease in Australia
Dev Jegatheesan
Effect of body mass index on long-term graft and patient outcomes in paediatric kidney only recipients
Maleeka Ladhani
The heterozygous P.R76W HNF4A variant is associated with atypical autosomal dominant De Toni-Fanconi-Debré Syndrome and can be diagnosed utilising diagnostic clinical exomic analysis
Andrew Mallett
Single dose rituximab in refractory autoimmune glomerulonephritis
Prasanti Kotagiri
The impact of socioeconomic status, geographic remoteness on pre-emptive transplant accessibility and transplant outcomes in children with end stage kidney disease
Germaine Wong
RMND1 mutations are associated with autosomal recessive syndromic nephropathy
Andrew Mallett
Clinical features and outcomes in patients with fibrillary and immunotactoid glomerulonephritis in South Australia
Georgina Irish
Predictors of abnormal glucose regulation (AGR) after kidney transplantation
Wai Lim
IL-17 upregulation facilitates injury in the early diabetic kidney
Jin Ma
Lunar: Lupus nephritis Australian registry baseline demographics
Nicole Isbel
Viral serological status and graft failure, death and cancer risk after kidney transplantation
Wai Lim
Investigating the role of C5a-CD88 signalling axis in diabetic nephropathy
Sih Min Tan
Mutations in the KCTD1 gene cause scalp-ear-nipple (‘Finlay-Marks’) syndrome: A further cause of thin basement membrane nephropathy and astigmatism
Judy Savige
Everolimus plus reduced-exposure cyclosporin versus mycophelonic acid plus cyclosporin: Seven year follow-up of ANZ patients from a randomised controlled trial
Steve Chadban
Links between urinary phosphate handling, FGF23 and Klotho: An Australian single-centre cross-sectional study
Sven-Jean Tan
Dendritic cell and effector cell TLR9 ligation play crucial roles in the pathogenesis of anti-myeloperoxidase glomerulonephritis
Sharon Ford
Normal saline versus lower-chloride solutions for kidney transplantation
Susan Wan
1300-1400 Lunch | Exhibition Area
PKD Foundation Meeting (invitation only) | Green Room
Seminar 3 Clinical Science | Royal Theatre
Advances in clinical testing and treatment
Chair: Kevan Polkinghorne
Basic Science Award | Bradman Theatrette
10 minute presentation + 5 minutes for questions
Chairs: Tim Hewitson & Glenda Gobe
1400-1415 Screening for cardiac disease 
A/Professor John Gill
Therapeutic targeting of CD20+ B cells for autoimmune MPO-ANCA glomerulonephritis
Poh-Yi Gan
1415-1430 Conditional deletion of JNK signalling in proximal tubular epithelial cells ameliorates renal ischaemia-reperfusion injury
Keren Grynberg
1430-1445 Prevention strategies for preeclampsia and future cardiovascular risk
Professor Annemarie Hennessy
Mineralocorticoid receptor activation acutely increases expression and phosphorylation of the thiazide sensitive sodium chloride cotransporter in humans
Martin Wolley
1445-1500 Placental growth factor reduces blood pressure in experimental preeclampsia
Angela Makris
1500-1515 New paradigms in Hepatitis C
A/Professor Catherine Stedman
VANGL1 copy number variation predisposes to nephritis in systemic lupus erythematosus
Simon Jiang
1515-1530 The SMAD3/SMAD4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction
Jinhua Li
1530-1600 Afternoon Tea | Exhibition Area
Mini Orals | 5 minute presentation + 2 minutes for questions
Shaun Summers Trainee Award | Royal Theatre
Chairs: Vincent Lee & Steve May
Dialysis 1 | Bradman Theatrette
Chair: Carmel Hawley & John Schollum
Other | Menzies Theatrette
Chairs: Paolo Ferrari & Matthew Roberts
1600-1700 Risk factors for multi-resistant E.Coli urinary tract infections in children: A case control study
Gayathri Raman
Effects of intravenous iron carboxymaltose versus iron sucrose on fibroblast growth factor-23 in patients receiving dialysis: A randomised controlled trial
Louis Huang
The NxStage home haemodialysis system: A single centre experience
Shyam Dheda
Late referral does not contribute to CKD progression in central Australia in adults commencing haemodialysis in 2012
Anna Holwell
Association between proanthocyanidin intake and aortic calcification in older women with chronic kidney disease
Wai Lim
Factors associated with nonresponse to the hepatitis B vaccine in dialysis patients
Nicole Leather
Antihypertensive treatment for kidney transplant recipients (KTR): An updated systematic review of randomised controlled trials
Pamela Mooi
The other side of adequacy: Why ultrafiltration rate must be put back in the spotlight
Emily See
Comparison of Freelite and N Latex serum free light chain assays in subjects with end stage renal disease on haemodialysis
Alice Kennard
Acute kidney injury post-major orthopaedic surgery: A single centre experience
Samantha Chan
Death due to dialysis access haemorrhage: Why does it happen and what are we doing about it?
Nicole Lioufas
Is there a ‘NIMA’ effect in the era of modern immunosuppression?
Wai Lim
Peritoneal dialysis catheter outcomes: Comparison between placement techniques in a single centre
Lani Shochet
A comparison of argyle anti reflux plastic cannulae and traditional steel needle use in a cohort of haemodialysis patients
Richard Mooney
Asymptomatic bacteriuria and urinary tract infection in kidney and simultaneous pancreas kidney transplant recipients
Devaki Chemboli
Experience and outcomes with long hours, alternate day nocturnal haemodialysis (ADNHD)
Shizhou Choo
Inflow diameter as a marker of radiocephalic fistula dysfunction
James Collett
Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients
Sunil Badve
Barriers to renal transplantation
Kathryn Ducharlet
Analysis of pre-treatment water supplies to our dialysis facilities in Victoria from 2009 to 2015
Blazhe Nedanovski
Autosomal dominant polycystic kidney disease: Utilisation of whole genome sequencing to identify PKD1 and PKD2 mutations
Amali Mallawaarachchi
Cumulative doses of T-cell depleting antibody and cancer risk after kidney transplantation
Jenny HC Chen
Rove study: Residual blood volume post haemodialysis
Rob MacGinley
Tryptophan metabolism in chronic kidney disease is related to the inflammation marker neopterin and to neurophyschological measures
Matthew Jose
1700-1800 Poster Session with nibbles and drinks in the exhibition area (poster authors to stand by their posters and answer questions from delegates)
1830 Coaches depart Crowne Plaza for Parliament House
1845 Pre-Dinner Drinks | Marble Foyer, Parliament House
1900 till late ANZSN ASM Dinner | Great Hall, Parliament House


Wednesday 9 September 2015
0730 Registration Desk & Speakers Preparation Room Open | National Convention Centre Foyer
Seminar 4 Clinical Science | Royal Theatre
Chair: Nicole Isbel
0900-0930 Translational innovation in renal medicine 
Professor Prabir Roy-Chaudhury
0930-1000 Methods for economic evaluation in end-stage kidney disease
A/Professor Rachael Morton
Plenary 3 | Royal Theatre
Chair: Carol Pollock
1000-1100 Keynote Speaker: Associate Professor John Gill
Living Donor Risk and Removal Of Disincentive to Living Kidney Donation
1100-1130 Morning Tea | Exhibition Area
ANZDATA Indigenous Working Group Networking Morning Tea (invitation only) | Green Room
Mini Orals | 5 minute presentation + 2 minutes for questions
Epidemiology 2 | Royal Theatre
Chairs: Suetonia Palmer &
Martin Gallagher
Pregnancy, Paediatrics and Quality of Life | Bradman Theatrette
Chairs: Sean Kennedy & Germaine Wong
Dialysis 2 | Menzies Theatrette
Chairs: Rob MacGinley & Girish Talaulikar
1130-1300 Obesity and the risk of all-cause and cardiovascular mortality across the spectrum of CKD: A systematic review and meta-analysis
Maleeka Ladhani
Health literacy in home dialysis
Louis Huang
Disparities in survival of dialysis patients in Australia based upon ethnicity and country of birth
Omar Azzam
Health literacy demand of printed lifestyle patient information materials aimed at people with chronic kidney disease
Angela Webster
Glucagon-like peptide-1 protects against the detrimental consequences of maternal obesity in offspring’s kidneys
Sarah Glastras
A survey of clinicians’ practices and attitudes to advance care planning for patients with chronic kidney disease
Lucy Spencer
Hospitalisations, independent of, or before, renal replacement therapy (RRT) in chronic kidney disease (CKD) patients in the renal practices of the Royal Brisbane and Womens Hospital (RBWH) in Queensland
Helen Healy
Maternal obesity accelerates the development of CKD in offspring with diabetes
Sarah Glastras
Content analysis of the quality of renal diet information available to people with kidney disease on the internet
Kelly Lambert
Predictors of renal replacement therapy (RRT) and death in chronic kidney disease (CKD) patients in a major Queensland metropolitan public renal practice
Helen Healy
Renal histology after TNF-a and reduced perfusion pressure-induced experimental preeclampsia
Annemarie Hennessy
Content analysis of the quality of renal diet information available to people with kidney disease on YouTube
Kelly Lambert
Further demonstration of associations of low birthweight with adult death and renal failure in a remote Aboriginal community
Wendy Hoy
Retinal abnormalities in gestational diabetes and preeclampsia
Judy Savige
Content analysis of the quality of diet-related smartphone applications for people with kidney disease
Kelly Lambert
Assessment of the coding of end-stage kidney disease (ESKD) in deaths and hospitalisation data
Graz Hamilton
Pregnancy outcomes in women with chronic kidney disease in South Australia
Alyssa Fitzpatrick
Patient factors associated with nonresponse to the hepatitis B vaccination in haemodialysis patients: A systematic review
Nicole Leather
Periodontitis and risk of all-cause and cardiovascular mortality in adults with end-stage kidney disease: A propensity-matched study
Suetonia Palmer
Perspectives of pregnancy in women with chronic kidney disease: An interview study
Allison Tong
Remote monitoring of home haemodialysis patients using a newly developed smart phone app
Kamal Sud
Healthcare and research priorities of adolescents and young adults with systemic lupus erythematosus
David Tunnicliffe
Symptom burden, quality of life and functional status in patients with chronic kidney disease
Kathryn Ducharlet
Effect of increased blood flow rate on dialysis tolerability and achieved urea reducation ratio
Peter Ryan
Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal dominant polycystic kidney disease
David Tunnicliffe
Prior procedural experience of renal trainees in an Australian metropolitan hospital renal unit providing interventional nephrology services
Jeffrey Kwok Wah Wong
Patient experiences of training and transition to home haemodialysis: A longitudinal mixed methods study
Camilla Hanson
Renal replacement therapy education and planning: Does the timing of referral matter?
Karumathil Murali
Dialysis outcomes in Australian adolescents and young adults
Sean Kennedy
The influence of the food experience on energy intake and weight gain in kidney transplant recipients
Nicole Isbel
Perceived nutrition management priorities and current practice in non-dialysis or conservative care
Maria Chan
Pregnancy after kidney transplantation in a South Australian cohort over 39 years
Fadak Mohammadi
Cognition in people on haemodialysis: A systematic review and meta-analysis
Emma O’Lone
Perceived nutrition management priorities and current practice in progressive chronic kidney disease stages 4-5
Maria Chan
Implementation of a rural clinical software system: Results of a 12 month pilot study
Geoff Kirkland
What’s wrong with missing dialysis? Pattern and outcomes of dialysis attendance in the Northern Territory, 1995-2011
Paul Lawton
1300-1400 Lunch | Exhibition Area – ANZSN ASM Close
Wednesday 9 September 2015
Renal Genetics Interest Group – 3rd Annual Renal Genetics Symposium
Symposium Convenors Andrew Mallett & Chirag Patel | Bradman Theatrette
Bookings essential – Indicate attendance during the ANZSN ASM Registration Process or email the Secretariat
Session 1: The Pipeline: From Clinic to Diagnosis and Research
1330-1350 Renal Genetic Clinic Outcomes
Dr Chirag Patel
1350-1410 Genetic diagnostics in inherited kidney disease – Principles, advances and practicalities
Dr Bruce Bennetts & Dr Kathy Holman
1410-1440 Functional genomics in inherited kidney disease
Prof. Melissa Little
Session 2: Strategising for an Effective and Collaborative Future
1440-1500 Forming an Australasian Renal Genetics Interest Group
Dr Steve Alexander
1500-1510 Break
1510-1520 Victorian Registry of Kidney Disease
Dr Scott Wilson
1520-1530 Australian aHUS/TTP Registry
A/Prof Shlomo Coney
1530-1600 Creating the ARK – Australasian Registry of rare Kidney conditions
Dr Hugh McCarthy
Session 3: Hosting City Research & Clinical Update
1600-1615 Genetic Autoimmune Renal Disease
Dr Simon Jiang
Session 4: Clinical Updates – A Focus on Cystic Kidney Diseases
1615-1630 ADPKD – Progress & an Update from the CARI-ADPKD Guideline
Prof. Judy Savige
1630-1645 NPHP and NPHP-RD
Dr Cathy Quinlan
1645-1700 ADTKD: The Condition Formerly Known as.
Dr Andrew Mallett
1700 Close
Recent Comments